Correlation Between Eyenovia and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Assembly Biosciences, you can compare the effects of market volatilities on Eyenovia and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Assembly Biosciences.

Diversification Opportunities for Eyenovia and Assembly Biosciences

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eyenovia and Assembly is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Eyenovia i.e., Eyenovia and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Eyenovia and Assembly Biosciences

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Assembly Biosciences. In addition to that, Eyenovia is 5.46 times more volatile than Assembly Biosciences. It trades about -0.26 of its total potential returns per unit of risk. Assembly Biosciences is currently generating about -0.05 per unit of volatility. If you would invest  1,771  in Assembly Biosciences on August 30, 2024 and sell it today you would lose (88.00) from holding Assembly Biosciences or give up 4.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Assembly Biosciences

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Assembly Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Assembly Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating primary indicators, Assembly Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Eyenovia and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Assembly Biosciences

The main advantage of trading using opposite Eyenovia and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Eyenovia and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope